20-hydroxy-5,8,11,14-eicosatetraenoic acid and Ischemic Attack, Transient

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Ischemic Attack, Transient in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukasawa, M; Horiuchi, N; Minagawa, T; Miyata, N; Nakaike, S; Omura, T; Tanaka, Y; Yoshida, S	1

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Ischemic Attack, Transient

Article	Year
Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats. Neuroscience research, 2007, Volume: 59, Issue:4 Topics: Animals; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Formamides; Hydroxyeicosatetraenoic Acids; Ischemic Attack, Transient; Morpholines; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome; Up-Regulation; Vasodilation	2007

Article

Year

Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.

Neuroscience research, 2007, Volume: 59, Issue:4

Topics: Animals; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Formamides; Hydroxyeicosatetraenoic Acids; Ischemic Attack, Transient; Morpholines; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome; Up-Regulation; Vasodilation

2007